{
  "incidence": 300000,
  "prevalence": 3800000,
  "subtype_shares": {
    "HER2+": 0.20
  },
  "stage_shares": {
    "adjuvant": 0.40,
    "neoadjuvant": 0.25,
    "metastatic": 0.35
  },
  "line_shares": {
    "1L": 1.0,
    "2L": 0.40
  },
  "time_on_treatment_months": {
    "1L": 15,
    "2L": 10
  }
}
